STOCK - BASED COMPENSATION | STOCK-BASED COMPENSATION 2021 Equity Incentive Plan In connection with the Company’s IPO, the Company adopted the 2021 Equity Incentive Plan (the “2021 Plan”), which allows for issuance of stock options (including incentive stock options and non-qualified stock options), RSUs, including performance-based awards, and other types of awards. The maximum number of shares of common stock that may be issued under the 2021 Plan is 35,166,753, which is the sum of (i) 11,500,000 new shares, plus (ii) an additional number of shares consisting of (a) shares that were available for the issuance of awards under any prior equity incentive plans in place (which shall include the Prior Stock Plans (as defined below) and the Spyce Plan (as defined below)) prior to the time the Company’s 2021 Plan became effective and (b) any shares of the Company’s common stock subject to outstanding stock options or other stock awards granted under the Prior Stock Plans that on or after the Company’s 2021 Plan became effective, terminate or expire prior to the exercise or settlement; are not issued because the award is settled in cash; are forfeited because of the failure to vest; or are reacquired or withheld (or not issued) to satisfy a tax withholding obligation or the purchase or exercise price. Options granted during, or prior to, the thirteen weeks ended March 27, 2022 generally have vesting terms between twelve months and four years and have a contractual life of 10 years. 2009 Stock Plan and 2019 Equity Incentive Plan Prior to the Company’s IPO, the Company granted stock options, RSUs and performance-based restricted stock awards (“PSUs”) to its employees, as well as nonemployees (including directors and others who provide substantial services to the Company) under the Company’s 2009 Stock Plan and 2019 Equity Incentive Plan (collectively, the “Prior Stock Plans”). Awards permitted to be granted under the Prior Stock Plans include incentive stock options to the Company’s employees and non-qualified stock options to the Company’s employees and non-employees, as well as stock appreciation rights, restricted stock awards, RSUs (including PSUs), and other forms of stock awards to the Company’s employees, directors and consultants and any of the Company’s affiliated employees and consultants. Options granted during the thirteen weeks ended March 27, 2022 and prior generally have vesting terms between one year and four years and have a contractual life of 10 years. No further stock awards will be granted under the Prior Stock Plans now that the 2021 Equity Incentive Plan is effective; however, awards outstanding under the Prior Stock Plans will continue to be governed by their existing terms. Spyce Acquisition In conjunction with the Spyce acquisition, the Company issued shares of Class S stock which converted to the Class A common stock upon the Company’s IPO. See Note 6. Shares of Class S stock that were issued to certain Spyce employees, and the corresponding shares of Class A common stock received by such employees in connection with the Company’s IPO, are subject to time-based service requirements and will vest on September 7, 2023, subject to vesting acceleration in full upon the occurrence of certain events. As the value is fixed, the grant date fair value of these shares represents the fair value of the shares on the acquisition date . For the thirteen weeks ended March 27, 2022, the Company recognized stock-based compensation expense of $0.8 million, related to the vested portion of such shares. 2021 Employee Stock Purchase Plan In conjunction with the IPO, the Company’s board of directors adopted, and the Company’s stockholders approved the Company’s 2021 employee stock purchase plan (the “ESPP”). The Company’s ESPP authorizes the issuance of 3,000,000 shares of common stock under purchase rights granted to the Company’s employees or to the employees of any of its designated affiliates. The number of shares of the Company’s common stock reserved for issuance will automatically increase on January 1 of each year for a period of 10 years, beginning January 1, 2023, by the lesser of (i) 1% of the total number of shares of our common stock outstanding on December 31 of the immediately preceding year; and (ii) 4,300,000 shares, except before the date of any such increase, the Company’s board of directors may determine that such increase will be less than the amount set forth in clauses (i) and (ii). As of March 27, 2022 , there had been no offering period or purchase period under the ESPP, and no such period will begin unless and until determined by the administrator. Stock Options Certain amounts for employee stock option disclosures in prior years were reclassified to conform with current year presentation. The following table summarizes the Company’s stock option activity for the thirteen weeks ended March 27, 2022 and March 28, 2021: (dollar amounts in thousands except per share amounts) Number of Shares Weighted Average Exercise Price Per Share Weighted-Average Remaining Contractual Term (In Years) Aggregate Intrinsic Value Balance—December 26, 2021 13,773,414 $ 6.87 7.42 $ 337,269 Options granted 369,274 25.39 Options exercised (153,158) 5.45 Options forfeited (53,721) 9.99 Options expired (11,197) 6.07 Balance—March 27, 2022 13,924,612 $ 7.37 7.31 $ 348,686 Exercisable—March 27, 2022 8,642,689 $ 5.07 6.31 $ 236,185 Vested and expected to vest—March 27, 2022 13,924,612 $ 7.37 7.31 $ 348,686 (dollar amounts in thousands except per share amounts) Number of Shares Weighted Average Exercise Price Per Share Weighted-Average Remaining Contractual Term (In Years) Aggregate Intrinsic Value Balance—December 27, 2020 14,612,730 $ 4.27 6.34 $ 15,204 Options granted — — Options exercised (561,465) 4.49 Options forfeited (117,673) 5.64 Options expired (61,498) 5.88 Balance—March 28, 2021 13,872,094 $ 4.24 6.29 $ 14,627 Exercisable—March 28, 2021 5,044,682 $ 4.80 4.80 $ 11,607 Vested and expected to vest—March 28, 2021 13,872,094 $ 4.24 6.29 $ 14,627 The weighted-average fair value of options granted during the thirteen weeks ended March 27, 2022, w as $11.16 for stock options issued. There were no options granted during the thirteen weeks ended March 28, 2021. The fair value of each option granted has b een estimated as of the date of the grant using the Black-Scholes option-pricing model. The Company has elected to account for forfeitures as they occur. As of March 27, 2022, there was $26.5 million in unrecognized compensation expense related to unvested stock-based compensation arrangements and is expected to be recognized over a weighted average period 2.45 years. Restricted Stock Units and Performance Stock Units Restricted stock units The following table summarizes the Company’s RSU activity for the thirteen weeks ended March 27, 2022: (dollar amounts in thousands except per share amounts) Number of Shares Weighted-Average Grant Date Fair Value Balance—December 26, 2021 2,392,426 $ 24.18 Granted 235,972 25.70 Released (12,500) 23.00 Forfeited, cancelled, or expired (60,711) 29.22 Balance— March 27, 2022 2,555,187 $ 24.21 There were no RSUs granted during the thirteen weeks ended March 28, 2021. As of March 27, 2022, unrecognized compensation expense related to RSUs was $53.3 million and is expected to be recognized over a weighted average period of 1.74 years. The fair value of shares released as of the vesting date during the thirteen weeks ended March 27, 2022 was $0.4 million. Performance stock units In October 2021, the Company granted 2,100,000 PSUs to each founder (the “founder PSUs”) for a total of 6,300,000 PSUs, under the 2019 Equity Incentive Plan. The founder PSUs vest upon the satisfaction of a service condition and the achievement of certain stock price goals. Subsequent to the Company’s IPO, the Company issued 321,428 PSUs to the Spyce founders (“Spyce PSUs”) based on three separate performance-based milestone targets. During the thirteen weeks ended March 27, 2022 , the Company has not recorded any stock-based compensation expense related to the Spyce PSUs. Unrecognized compensation expense related to the Spyce PSUs was $9.8 million, which will be expensed if the performance-based milestones targets become probable of being met. There were no additional PSU grants during the thirteen weeks ended March 27, 2022. As of March 27, 2022 unrecognized compensation expense related to the founder PSUs was $87.7 million and is expected to recognized over a weighted average perio d of 2.73 years. A summary of stock-based compensation expense recognized during the thirteen weeks ended March 27, 2022 and March 28, 2021 is as follows: (dollar amounts in thousands) March 27, March 28, Stock-options $ 2,532 $ 1,224 Restricted stock units 10,584 — Performance stock units 9,049 — Total stock-based compensation $ 22,165 $ 1,224 |